Singapore-based JV to commercialise MedAdvisor platform under exclusive licence for Asia.
Listed medication management specialist MedAdvisor Limited has just announced an agreement with Zuellig Pharma to form a 50/50 joint venture based in Singapore.
The JV will commercialise MedAdvisor’s medication management platform in Asia under an exclusive licence agreement, with the system to be marketed to Zuellig Pharma’s network of pharmacies, medical clinics and pharmaceutical manufacturers in selected target markets.
The initial launch will see the system debut in the Philippines and South Korea in the 2019/20 financial year, with other Asian markets to follow. Those two countries alone comprise a market totalling an estimated 48,000 pharmacies.
More information in tomorrow’s issue of Pharmacy Daily.
